Article
Clinical importance of prothrombotic risk factors in pediatric patients with malignancy--impact of central venous lines.
European journal of pediatrics - 1 Dec 1999
Knöfler R, Siegert E, Lauterbach I, Taut-Sack H, Siegert G, Gehrisch S, Müller D, Rupprecht E, Kabus M
Abstract excerpt
UNLABELLED: To evaluate the role of inherited thrombophilia in the development of central venous line (CVL)-related thrombosis, the following parameters were determined in 77 pediatric-oncologic patients with CVL: activated protein C (APC)-ratio, factor V (FV) G1691A and prothrombin G20210A mutation, protein C, protein S, antithrombin, coagulation factor XII, lipoprotein (a) and homocysteine. An inherited...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
